149 related articles for article (PubMed ID: 9858870)
1. Heparin fails to inhibit the proliferation of human vascular smooth muscle cells in the presence of human serum.
Underwood PA; Mitchell SM; Whitelock JM
J Vasc Res; 1998; 35(6):449-60. PubMed ID: 9858870
[TBL] [Abstract][Full Text] [Related]
2. Low density lipoproteins in human plasma make vascular smooth muscle cells resistant to growth inhibition by heparin.
Underwood PA; Mitchell SM
Cardiovasc Res; 2000 Sep; 47(4):749-58. PubMed ID: 10974223
[TBL] [Abstract][Full Text] [Related]
3. The antimitogenic action of the sulphated polysaccharide fucoidan differs from heparin in human vascular smooth muscle cells.
Patel MK; Mulloy B; Gallagher KL; O'Brien L; Hughes AD
Thromb Haemost; 2002 Jan; 87(1):149-54. PubMed ID: 11848445
[TBL] [Abstract][Full Text] [Related]
4. Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries. The role of heparin-sensitive and -insensitive pathways in the stimulation of smooth muscle cell migration and proliferation.
Geary RL; Koyama N; Wang TW; Vergel S; Clowes AW
Circulation; 1995 Jun; 91(12):2972-81. PubMed ID: 7796508
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta 1 and ascorbate regulate proliferation of cultured smooth muscle cells by independent mechanisms.
Ivanov VO; Rabovsky AB; Ivanova SV; Niedzwiecki A
Atherosclerosis; 1998 Sep; 140(1):25-34. PubMed ID: 9733212
[TBL] [Abstract][Full Text] [Related]
6. Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor beta-like activity from serum.
Grainger DJ; Witchell CM; Watson JV; Metcalfe JC; Weissberg PL
Cardiovasc Res; 1993 Dec; 27(12):2238-47. PubMed ID: 8313434
[TBL] [Abstract][Full Text] [Related]
7. The regulation of caveolin expression and localization by serum and heparin in vascular smooth muscle cells.
Peterson TE; Kleppe LS; Caplice NM; Pan S; Mueske CS; Simari RD
Biochem Biophys Res Commun; 1999 Nov; 265(3):722-7. PubMed ID: 10600487
[TBL] [Abstract][Full Text] [Related]
8. Human arterial smooth muscle cells in culture. Effects of platelet-derived growth factor and heparin on growth in vitro.
Fager G; Hansson GK; Ottosson P; Dahllöf B; Bondjers G
Exp Cell Res; 1988 Jun; 176(2):319-35. PubMed ID: 2837401
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration.
Pukac L; Huangpu J; Karnovsky MJ
Exp Cell Res; 1998 Aug; 242(2):548-60. PubMed ID: 9683541
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of vascular smooth muscle cell proliferation by a novel fibroblast growth factor receptor antagonist.
Segev A; Aviezer D; Safran M; Gross Z; Yayon A
Cardiovasc Res; 2002 Jan; 53(1):232-41. PubMed ID: 11744033
[TBL] [Abstract][Full Text] [Related]
11. Characterization of [3H]-heparin binding in human vascular smooth muscle cells and its relationship to the inhibition of DNA synthesis.
Patel MK; Refson JS; Schachter M; Hughes AD
Br J Pharmacol; 1999 May; 127(2):361-8. PubMed ID: 10385234
[TBL] [Abstract][Full Text] [Related]
12. Heparin inhibits proliferation of fetal vascular smooth muscle cells in the absence of platelet-derived growth factor.
Benitz WE; Lessler DS; Coulson JD; Bernfield M
J Cell Physiol; 1986 Apr; 127(1):1-7. PubMed ID: 2420809
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin.
Weber H; Taylor DS; Molloy CJ
J Clin Invest; 1994 Feb; 93(2):788-98. PubMed ID: 7509348
[TBL] [Abstract][Full Text] [Related]
14. Decreased susceptibility of cultured smooth muscle cells from SHR rats to growth inhibition by heparin.
Resink TJ; Scott-Burden T; Baur U; Bürgin M; Bühler FR
J Cell Physiol; 1989 Jan; 138(1):137-44. PubMed ID: 2910881
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
[TBL] [Abstract][Full Text] [Related]
16. COP-1, a member of the CCN family, is a heparin-induced growth arrest specific gene in vascular smooth muscle cells.
Delmolino LM; Stearns NA; Castellot JJ
J Cell Physiol; 2001 Jul; 188(1):45-55. PubMed ID: 11382921
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein D inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferated by preventing translocation of phosphorylated extracellular signal regulated kinase 1/2 to the nucleus.
Sarjeant JM; Lawrie A; Kinnear C; Yablonsky S; Leung W; Massaeli H; Prichett W; Veinot JP; Rassart E; Rabinovitch M
Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2172-7. PubMed ID: 14551159
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein J inhibits the migration, adhesion, and proliferation of vascular smooth muscle cells.
Sivamurthy N; Stone DH; Logerfo FW; Quist WC
J Vasc Surg; 2001 Oct; 34(4):716-23. PubMed ID: 11668329
[TBL] [Abstract][Full Text] [Related]
19. Factor VII-activating protease (FSAP) inhibits growth factor-mediated cell proliferation and migration of vascular smooth muscle cells.
Kannemeier C; Al-Fakhri N; Preissner KT; Kanse SM
FASEB J; 2004 Apr; 18(6):728-30. PubMed ID: 14977886
[TBL] [Abstract][Full Text] [Related]
20. Proliferation of human aortic vascular smooth muscle cells in culture is modulated by active TGF beta.
Kirschenlohr HL; Metcalfe JC; Weissberg PL; Grainger DJ
Cardiovasc Res; 1995 Jun; 29(6):848-55. PubMed ID: 7656289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
